Figure 1
Figure 1. Four-year Event-free and Overall Survival. Events: failures according to ELN 2013 recommendations, permanent discontinuation of nilotinib for any cause, including deaths

Four-year Event-free and Overall Survival. Events: failures according to ELN 2013 recommendations, permanent discontinuation of nilotinib for any cause, including deaths

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal